RKLB heads into Q2 with strong revenue growth prospects, but premium valuation, weak ROIC and Neutron costs cloud the investment case.
Rocket Lab remains a strong buy, with a $128.56 price target and 72% upside potential driven by organic and inorganic growth. RKLB's vertical integration is largely complete post-Iridium acquisition, enabling end-to-end capabilities from satellite components to operations and enhancing competitiveness. Recent major government contracts, including a $266M suborbital launch deal and an $816M satellite contract, validate RKLB's dual-use product strategy and defense market pivot.
There are four major tech names reporting earnings next week that I've put on my calendar, and you should too.
Rocket Lab is positioned as the second most important US satellite launch provider, with future growth hinging on the Neutron rocket. Neutron's timely launch is critical; delays could increase dilution risk due to the Iridium acquisition's equity component and refinancing needs. The Iridium acquisition transforms RKLB into a fully integrated space company, providing global spectrum, pole-to-pole coverage, and immediate profitability benefits.
The stock has fallen more than 13% so far this year. It has improved profitability but isn't turning a profit yet.
Rocket Lab has fallen more than 40%, yet the proposed Iridium acquisition and expanding defense business have materially strengthened its long-term outlook. The $266 million U.S. Space Force contract and $17 billion Phase 3 program expansion position defense as a major independent growth driver. Wall Street expects around 60% revenue growth in Q2, while Rocket Lab has exceeded revenue estimates in four consecutive quarters and seven of ten.
Rocket Lab (NASDAQ: RKLB | RKLB Price Prediction) has been volatile this year.
Rocket Lab's stock price has remained under intense pressure this week, falling to a key technical support level. After surging to a record high of $151 ahead of the SpaceX IPO, the stock has tumbled about 61% to around $58.60 as investors continue to take profits and reassess growth expectations.
In the most recent trading session, Rocket Lab Corporation (RKLB) closed at $63.89, indicating a -4.56% shift from the previous trading day.
Rocket Lab has reset sharply from its May highs, shifting investor focus from narrative to execution ahead of the August 10th earnings call. The investment thesis centers on sustained revenue growth, stable margins, and milestone-driven Neutron progress, with late-2026 launch credibility as the key catalyst. The VICTUS HAZE mission showcased RKLB's end-to-end, defense-grade space capabilities, reinforcing its evolution into a vertically integrated space platform.
Rocket Lab shares have fallen 33% since my last coverage despite Iridium, defense wins, and continued Neutron commercialization progress. The company is becoming increasingly diversified through defense programs, vertical integration, and the transformative Iridium acquisition beyond launch services. Neutron has evolved from a technical milestone into the primary financial catalyst supporting future margins, cash flow, and earnings expansion.
Rocket Lab and Intuitive Machines expand launch, spacecraft and lunar mission capabilities as growing space investments create new long-term opportunities.